143 related articles for article (PubMed ID: 26098603)
1. Perioperative quality of life in functionally dependent glioblastoma patients: A prospective study.
Jakola AS; Sagberg LM; Gulati S; Solheim O
Br J Neurosurg; 2015; 29(6):843-9. PubMed ID: 26098603
[TBL] [Abstract][Full Text] [Related]
2. Quality of life in patients with intracranial gliomas: the impact of modern image-guided surgery.
Jakola AS; Unsgård G; Solheim O
J Neurosurg; 2011 Jun; 114(6):1622-30. PubMed ID: 21314270
[TBL] [Abstract][Full Text] [Related]
3. Quality of survival the 1st year with glioblastoma: a longitudinal study of patient-reported quality of life.
Sagberg LM; Solheim O; Jakola AS
J Neurosurg; 2016 Apr; 124(4):989-97. PubMed ID: 26430849
[TBL] [Abstract][Full Text] [Related]
4. The influence of maximum safe resection of glioblastoma on survival in 1229 patients: Can we do better than gross-total resection?
Li YM; Suki D; Hess K; Sawaya R
J Neurosurg; 2016 Apr; 124(4):977-88. PubMed ID: 26495941
[TBL] [Abstract][Full Text] [Related]
5. The risk of getting worse: surgically acquired deficits, perioperative complications, and functional outcomes after primary resection of glioblastoma.
Gulati S; Jakola AS; Nerland US; Weber C; Solheim O
World Neurosurg; 2011 Dec; 76(6):572-9. PubMed ID: 22251506
[TBL] [Abstract][Full Text] [Related]
6. Factors involved in maintaining prolonged functional independence following supratentorial glioblastoma resection. Clinical article.
Chaichana KL; Halthore AN; Parker SL; Olivi A; Weingart JD; Brem H; Quinones-Hinojosa A
J Neurosurg; 2011 Mar; 114(3):604-12. PubMed ID: 20524825
[TBL] [Abstract][Full Text] [Related]
7. Glioblastoma in the elderly: the effect of aggressive and modern therapies on survival.
Babu R; Komisarow JM; Agarwal VJ; Rahimpour S; Iyer A; Britt D; Karikari IO; Grossi PM; Thomas S; Friedman AH; Adamson C
J Neurosurg; 2016 Apr; 124(4):998-1007. PubMed ID: 26452121
[TBL] [Abstract][Full Text] [Related]
8. Treatment outcomes for patients with glioblastoma multiforme and a low Karnofsky Performance Scale score on presentation to a tertiary care institution. Clinical article.
Marina O; Suh JH; Reddy CA; Barnett GH; Vogelbaum MA; Peereboom DM; Stevens GH; Elinzano H; Chao ST
J Neurosurg; 2011 Aug; 115(2):220-9. PubMed ID: 21548745
[TBL] [Abstract][Full Text] [Related]
9. Perioperative and Postoperative Quality of Life in Patients with Glioma-A Longitudinal Cohort Study.
Drewes C; Sagberg LM; Jakola AS; Solheim O
World Neurosurg; 2018 Sep; 117():e465-e474. PubMed ID: 29920391
[TBL] [Abstract][Full Text] [Related]
10. Survival prognostic factors in patients with glioblastoma: our experience.
Raysi Dehcordi S; De Paulis D; Marzi S; Ricci A; Cimini A; Cifone MG; Galzio RJ
J Neurosurg Sci; 2012 Sep; 56(3):239-45. PubMed ID: 22854592
[TBL] [Abstract][Full Text] [Related]
11. Surgical treatment of glioblastoma in the elderly: the impact of complications.
Karsy M; Yoon N; Boettcher L; Jensen R; Shah L; MacDonald J; Menacho ST
J Neurooncol; 2018 May; 138(1):123-132. PubMed ID: 29392589
[TBL] [Abstract][Full Text] [Related]
12. Experiences with reoperation on recurrent glioblastoma multiforme.
Pinsker M; Lumenta C
Zentralbl Neurochir; 2001; 62(2):43-7. PubMed ID: 11786935
[TBL] [Abstract][Full Text] [Related]
13. The relative value of postoperative versus preoperative Karnofsky Performance Scale scores as a predictor of survival after surgical resection of glioblastoma multiforme.
Chambless LB; Kistka HM; Parker SL; Hassam-Malani L; McGirt MJ; Thompson RC
J Neurooncol; 2015 Jan; 121(2):359-64. PubMed ID: 25344883
[TBL] [Abstract][Full Text] [Related]
14. Effects of surgical resection on the evolution of quality of life in newly diagnosed patients with glioblastoma: a report on 19 patients surviving to follow-up.
Daigle K; Fortin D; Mathieu D; Saint-Pierre AB; Paré FM; de la Sablonnière A; Goffaux P
Curr Med Res Opin; 2013 Oct; 29(10):1307-13. PubMed ID: 23844725
[TBL] [Abstract][Full Text] [Related]
15. Role of adjuvant or salvage radiosurgery in the management of unresected residual or progressive glioblastoma multiforme in the pre-bevacizumab era.
Niranjan A; Kano H; Iyer A; Kondziolka D; Flickinger JC; Lunsford LD
J Neurosurg; 2015 Apr; 122(4):757-65. PubMed ID: 25594327
[TBL] [Abstract][Full Text] [Related]
16. Preservation of quality of life by preradiotherapy stereotactic radiosurgery for unresectable glioblastoma multiforme.
Kong DS; Nam DH; Lee JI; Park K; Kim JH
J Neurosurg; 2006 Dec; 105 Suppl():139-43. PubMed ID: 18503347
[TBL] [Abstract][Full Text] [Related]
17. Glioblastoma surgery with and without intraoperative MRI at 3.0T.
Napolitano M; Vaz G; Lawson TM; Docquier MA; van Maanen A; Duprez T; Raftopoulos C
Neurochirurgie; 2014 Aug; 60(4):143-50. PubMed ID: 24975207
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of MGMT promoter status in non-resectable glioblastoma after adjuvant therapy.
Iaccarino C; Orlandi E; Ruggeri F; Nicoli D; Torricelli F; Maggi M; Cerasti D; Pisanello A; Pedrazzi G; Froio E; Crafa P; D'Abbiero N; Michiara M; Ghadirpour R; Servadei F
Clin Neurol Neurosurg; 2015 May; 132():1-8. PubMed ID: 25723791
[TBL] [Abstract][Full Text] [Related]
19. Multiple craniotomies in the management of multifocal and multicentric glioblastoma. Clinical article.
Hassaneen W; Levine NB; Suki D; Salaskar AL; de Moura Lima A; McCutcheon IE; Prabhu SS; Lang FF; DeMonte F; Rao G; Weinberg JS; Wildrick DM; Aldape KD; Sawaya R
J Neurosurg; 2011 Mar; 114(3):576-84. PubMed ID: 20690813
[TBL] [Abstract][Full Text] [Related]
20. Resection versus biopsy of glioblastomas in eloquent brain areas.
Hrabalek L; Kalita O; Vaverka M; Zlevorova M; Ehrmann J; Cechakova E; Adamus M; Novak V; Langova K
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2015 Mar; 159(1):150-5. PubMed ID: 23945847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
